Market News

Procter & Gamble Q2 Earnings: Unpacking Performance and Market PredictionsProcter & Gamble Q2 Earnings: Unpacking Performance and Market Predictions

Procter & Gamble Co PG, will be reporting its second-quarter earnings on Tuesday. Wall Street will be expecting the company to report $1.70 in EPS and $21.47 billion in revenue as it reports before market hours. Procter & Gamble, also known as P&G, is the …

Read more

Insiders Buying Penny Stocks Insiders Buy Penny Stocks on the Cheap – A Sign of Uptrend?

The Dow Jones index closed higher by over 100 points on Monday, sparking optimism on Wall Street. However, even pennies can make the purse jingle, as recent insider transactions for Allied Gaming & Entertainment, Vivani Medical, and Catheter Precision show. When insiders purchase or sell …

Read more

PACCAR (PCAR) Earnings Forecast for Q4 2023 PACCAR (PCAR) Earnings Forecast for Q4 2023

Tomorrow, before market open, PACCAR (PCAR) is set to release its fourth-quarter 2023 results. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share and revenues is $2.20 and $8.18 billion, respectively. The consensus estimate for PACCAR’s earnings per share has increased by 3 …

Read more

3 Stocks Poised for Major Growth in 2024

If you’re looking for top stocks this month, look no further. After robust gains in 2023, the stock market is off to a sluggish start this year. The S&P 500 remains largely unchanged, jerking about due to conflicting economic signals. Once confident that the Federal …

Read more

Tesla (NASDAQ:TSLA) Q4 Earnings Preview Anticipation Builds as Tesla Prepares to Release Q4 Earnings

Tesla (NASDAQ:TSLA) is gearing up to reveal its financial results for the fourth quarter of 2023 on Wednesday, January 24. The electric vehicle (EV) giant is expected to see a boost in top-line growth due to higher deliveries, while the bottom line may face pressure …

Read more

Procter & Gamble Impresses with Margin Growth in FQ2 Procter & Gamble Impresses with Margin Growth in FQ2

SOPA Images/LightRocket via Getty Images Procter & Gamble Company (NYSE:PG) saw an uptick in early trading on Tuesday after unveiling a FQ2 earnings report that left investors with mixed sentiments. The company’s organic sales rose 4% during the quarter— a slightly shy of the +4.6% …

Read more

Insight into Beyond Meat’s Options Market Insight into Beyond Meat’s Options Market

Benzinga’s options scanner just discovered over 9 options trades for Beyond Meat BYND, totaling $459,745. Simultaneously, our algo intercepted 7 trades, amounting to $442,745 in total. Insights into Price Target Taking into account the Volume and Open Interest on these contracts, it seems that whales …

Read more

Investment News: Stocks with Great Relative Strength Investment News: Stocks with Great Relative Strength

High-Performing Stocks Near 52-Week Highs As the market reflects positive momentum, a number of stocks are either approaching or surpassing their 52-week highs. Among these, renowned names such as Amazon (AMZN), Arista Networks (ANET), and Abercrombie & Fitch (ANF) have demonstrated exceptional performance against the …

Read more

Pfizer, Autodesk, and AbbVie in Focus Investment Insights: Pfizer, Autodesk, and AbbVie in Focus

On CNBC’s “Halftime Report Final Trades,” Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund XLV as her final trade. Joshua Brown of Ritholtz Wealth Management picked Pfizer Inc. PFE, which bottomed in the middle of December. At the JPMorgan …

Read more

Breaking Ground: First Wave BioPharma Primed for Phase 3 Clinical TrialsBreaking Ground: First Wave BioPharma Primed for Phase 3 Clinical Trials

Company Vision During a recent appearance on Benzinga’s All-Access, James Sapirstein, Chairman, President & CEO of First Wave BioPharma, Inc. (NASDAQ:FWBI) shared insights about the company’s mission. First Wave BioPharma is a clinical-stage biopharmaceutical company with a dedicated focus on developing targeted, non-systemic therapies for …

Read more